+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intravenous Equipment: Global Strategic Business Report

  • PDF Icon

    Report

  • 218 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 338861

Global Intravenous Equipment Market to Reach $14.2 Billion by 2030

The global market for Intravenous Equipment estimated at US$10.6 Billion in the year 2022, is projected to reach a revised size of US$14.2 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2022-2030. IV Catheters, one of the segments analyzed in the report, is projected to record a 4.1% CAGR and reach US$4.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Securement Devices segment is readjusted to a revised 4.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.9 Billion, While China is Forecast to Grow at 6.4% CAGR

The Intravenous Equipment market in the U.S. is estimated at US$2.9 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 6.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.9% and 4.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.9 Billion by the year 2030.

Select Competitors (Total 91 Featured) -

  • AngioDynamics Inc.
  • Arcomed AG
  • ASCOR S.A.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Fresenius SE & Co. KGaA
  • Halyard Health Inc.
  • ICU Medical Inc.
  • Insulet Corp.
  • Medtronic PLC
  • Moog Inc.
  • Nipro Corporation
  • Smiths Medical
  • Tandem Diabetes Care Inc.
  • Teleflex Inc.
  • Terumo Corp.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Intravenous Equipment Market on a Steady Growth Path
  • Recent Market Activity
  • Uptrend in Healthcare Expenditure Creates Substantial Opportunities
  • Developed Regions Remain Primary Revenue Contributors
  • Developing Regions Exhibit Immense Growth Potential
  • Key Factors Driving Sales of IV Equipment in Developing Regions
  • Increase in Number of Hospitals
  • Growing Healthcare Awareness & Parallel Increase in Consumer Healthcare Spending
  • Proliferation of Medical Tourism
  • Stable Economic Scenario Lends Momentum for Market Growth
  • Competitive Scenario
  • Leading Players in the World Intravenous Equipment Market
  • Medtronic Leads the Insulin Pumps Market
  • C. R. Bard Predominates the PICC Market
  • Competitive Factors in the Intravenous Equipment Market
  • Competition: Noteworthy Trends
  • Tough Ground for New Entrants
  • ICR: A Key Factor to Success
  • Expiry of Warranty Provides New Opportunities to Insulin Pump Makers
  • Customer Satisfaction: Crucial to Stay Competitive
  • Market Witnesses High-Profile M&A Deals
  • Select M&A Deals Finalized in the Intravenous Equipment Market in the Recent Past
  • Intravenous Equipment - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
  • AngioDynamics, Inc. (USA)
  • Arcomed AG (Switzerland)
  • ASCOR S.A. (Poland)
  • B. Braun Melsungen AG (Germany)
  • Baxter International, Inc. (USA)
  • Becton, Dickinson and Company (USA)
  • C.R. Bard, Inc. (USA)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Fresenius SE & Co. KGaA (Germany)
  • Halyard Health, Inc. (USA)
  • ICU Medical, Inc. (USA)
  • Insulet Corp. (USA)
  • Medtronic, PLC (Ireland)
  • Moog, Inc. (USA)
  • Nipro Corporation (Japan)
  • Smiths Medical (USA)
  • Tandem Diabetes Care, Inc. (USA)
  • Teleflex, Inc. (USA)
  • Terumo Corp. (Japan)
3. MARKET TRENDS & DRIVERS
  • Infusion Pumps & Sets: The Largest & Fastest Growing Product Segment
  • Infusion Pump Market Slated to Gain Further Momentum
  • Insulin Pumps Market - Set for Interesting Road Ahead
  • Intravenous Catheters Market Scenario
  • Peripheral Intravenous Catheters Market - An Insight
  • Positive Outlook for Central Venous Catheters
  • Rising Incidence of Chronic Diseases Fuels Intravenous Equipment Demand
  • The Diabetes Epidemic - Untapped Potential for Insulin Pumps
  • Cancer Pain Offers Potential Opportunities for Pain Management Pumps
  • Aging Population: A Strong Growth Driver
  • Global Aging Population Statistics - Opportunity Indicators
  • Alternative Site Care: Shaping the Intravenous Equipment Market
  • IV Infusion Pumps: An Obvious Beneficiary of the Rise in Alternate Care Sites
  • Widening Use of Disposable Infusion Pumps
  • Smart Infusion Systems: Marking the Convergence of Healthcare IT & IV Drug Delivery Systems
  • Beating the Odds
  • Three Key Factors Driving Hospital Adoption of Smart Infusion Systems
  • Market Characterized by Price Competitiveness
  • Remote-Control Catheters - A Possible Technology
  • New Software Promises More Safety in Usage of Intravenous Infusion Pumps
  • Adoption of Integrated Systems Propels Catheter Stabilization Device Market
  • Artificial Arteriovenous Fistulae Developed for Safe use of Intravenous Equipment
  • Ultrasound Aided Insertion of Peripheral Intravenous Catheters
  • Accidental Needlestick Injuries: A Thing of the Past
  • Technology Advancements in PICC Space
  • Safety of Intravenous Catheters Outclassed
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Intravenous Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Intravenous Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 3: World 18-Year Perspective for Intravenous Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for IV Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for IV Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 6: World 18-Year Perspective for IV Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Securement Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Securement Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 9: World 18-Year Perspective for Securement Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Administration Sets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Administration Sets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 12: World 18-Year Perspective for Administration Sets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Infusion Sets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Infusion Sets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 15: World 18-Year Perspective for Infusion Sets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Drip Chambers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Drip Chambers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 18: World 18-Year Perspective for Drip Chambers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 21: World 18-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 23: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 24: World 18-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 26: World Historic Review for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 27: World 18-Year Perspective for Ambulatory Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 28: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 30: World 18-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 31: World Intravenous Equipment Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Intravenous Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
CANADA
JAPAN
  • Intravenous Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
CHINA
  • Intravenous Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
EUROPE
  • Intravenous Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
FRANCE
  • Intravenous Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
GERMANY
  • Intravenous Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
ITALY
UNITED KINGDOM
  • Intravenous Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Intravenous Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
AUSTRALIA
  • Intravenous Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Intravenous Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Intravenous Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Intravenous Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Intravenous Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AngioDynamics Inc.
  • Arcomed AG
  • ASCOR S.A.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Fresenius SE & Co. KGaA
  • Halyard Health Inc.
  • ICU Medical Inc.
  • Insulet Corp.
  • Medtronic PLC
  • Moog Inc.
  • Nipro Corporation
  • Smiths Medical
  • Tandem Diabetes Care Inc.
  • Teleflex Inc.
  • Terumo Corp.

Table Information